REGENERON PHARMACEUTICALS, INC. - Portfolio overview

REGENERON PHARMACEUTICALS, INC. has 4 reported holdings in this dataset, with the latest filing dated 2026-05-08.

Its largest classified asset exposures are stocks.

Its largest classified sector exposures are Healthcare.

Largest reported holdings by portfolio allocation

1. ALNY - Alnylam Pharmaceuticals, Inc., 92.88%
2. NTLA - Intellia Therapeutics, Inc., 6.94%
3. ADVM - Adverum Biotechnologies, Inc., 0.12%

These figures describe reported SEC 13F holdings, which may not represent the institution's entire portfolio or current positions.

Explore securities or join Upside Invest to compare portfolios.